Close
ACHEMA MIDDLE EAST 2026

One reason clinical trials for Alzheimer’s disease have failed — And the digital biomarker that could help address that

Introducing a new disease-modifying therapy, from research through to launch, is an extremely complex process, with lengthy and expensive drug development cycles. While clinical...

Shire and Rani Therapeutics enter into collaboration to evaluate use of the Rani Pill™ technology for the oral delivery of factor therapy

Shire plc , the biotech leader in rare diseases, and Rani Therapeutics, an InCube Labs company, announced a collaboration to exclusively conduct research on...

Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has established a new agreement with clinical-stage gene therapy...

Eone-Diagnomics Genome Center developed the world’s first non-invasive prenatal test algorithms using AI technology

Eone-Diagnomics Genome Center (EDGC), a Korean genetic analysis company, said today that it has started applying machine learning-based Artificial Intelligence (AI) technology to its...

Merck’s Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada

Merck, a leading science and technology company, today announced that Health Canada has approved MAVENCLAD™ (Cladribine Tablets) as monotherapy for the treatment of adult...

Dance Biopharm and Phillips-Medisize Enter into Joint Development Agreement for Advanced Inhaled Insulin Delivery

Dance Biopharm Holdings Inc. ("Dance"), a privately-held biotechnology company focused on the development of Dance 501, a proprietary 'soft-mist' inhaled insulin product to treat...

AgriLabs® Develops Master Seeds for Adenovirus Vectored Foot-and-Mouth Disease Vaccines

AgriLabs® today announced that it has developed a set of master seeds for a replication-deficient human adenovirus vector that expresses select genes for several...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...